Percepta -- Bioscience questions answered.Percepta -- Bioscience questions answered.Percepta -- Bioscience questions answered.
bioscience. questions. answered.

In US and Canada Call Toll Free: (877) 597-9236
Everywhere Else Call: (760) 431-6300

Blog, Polls

Synthetic Biology Building Momentum with Researchers

Mason Brooks

31st Jan, 2014

Blog, Polls

0

With the explosion of biological data now available as a direct result of genome sequencing initiatives, use of commercial gene synthesis and pre-designed synthetic biology tools is becoming increasingly popular. We wanted to understand how molecular cloners feel about using synthetic biology tools as replacements for in-house methods such as cloning. So, in December 2013, we polled users of…

read more >

Protein Analysis Products: Effect of U.S. Sequester

Mason Brooks

25th Nov, 2013

Articles, Blog, Polls

0

In October 2013, we polled users of protein analysis products in the U.S. to understand how, if at all, budget sequestration has affected their lab’s purchase of protein analysis products.  Results reveal that both non-profit and for-profit researchers are impacted by budget sequestration as approximately 56% of non-profit and 29% of for-profit respondents indicated budget sequestration has definitely affected…

read more >

Top Bioinformatics Concerns for NGS Researchers

percepta

10th Oct, 2013

Blog, Polls

0

What are the top bioinformatics concerns for researchers that perform next-generation sequencing? We wanted to understand their “top of mind” concerns and not prompt users with a list of potential answers from which to choose.  So, we asked over 400 scientists in government, private, commercial and academic labs in the United States, all involved in performing next generation sequencing,…

read more >

Customer Opinion on Most Flexible Pricing Options – Life Science Reagent and Instrument Suppliers

percepta

1st Oct, 2013

Blog, Polls

0

We set out to understand, at a top level, which life science suppliers are recognized in the industry for having the most flexible pricing options, for reagents and for instruments.  The questions posed to North American, European and Chinese audiences were:

Q. Which life science reagent supplier has the most flexible pricing options?

Q. Which life science instrument supplier…

read more >

Customer Opinion on Most Memorable Life Science Reagent and Instrument Advertisements

percepta

10th Sep, 2013

Blog, Polls

0

We set out to understand, at a top level, which life science suppliers are recognized in the industry for having the most memorable advertising, for reagents and for instruments.  The questions posed to North American, European and Chinese audiences were:

Q. Which life science reagent supplier has the most memorable advertising?

Q. Which life science instrument supplier has the…

read more >

Customer Opinion of Thermo Fisher-Life Technologies Merger

percepta

17th Apr, 2013

Polls

0

We asked 2,172 researchers around the world what they thought of the announcement that Thermo Fisher Scientific is acquiring Life Technologies.  Less than 24 hours after the announcement roughly half of the participants (49%) were aware of the news.  The fact that this news has spread this quickly is a testament to the considerable impact this merger is likely…

read more >

Poll of Fluorescent Imaging Reagent User Budgets Reveals Commercial Users more Optimistic

percepta

12th Feb, 2013

Blog, Polls

0

In February 2013 we polled our panel of fluorescent imaging reagent users regarding their anticipated laboratory budget. Data reveals that commercial users anticipate a slight increase compared to academic users. As shown in the table, 24.1% of commercial users of fluorescent imaging reagents expect their budget to increase over the next 12 months, vs. 17.6% of academic users (a…

read more >

Take Another Look at Cell Therapy

percepta

5th Feb, 2013

Blog, Polls

0

If you thought cell therapy had suffered too many setbacks in recent years and was stuck in neutral – think again. In a recent Percepta poll of 250 randomly selected life science researchers working in biotechnology and pharmaceutical companies more than 20% are involved in projects focused on allogeneic or autologous cell therapy and/or regenerative medicine. Even more surprising…

read more >

Copyright © 2017 Percepta Associates Inc. All rights reserved. Terms & Conditions.Designed by Audacity